Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease

Timir K. Paul, Mamas A. Mamas, Madhan Shanmugasundaram, Harsha S. Nagarajarao, Chandra P. Ojha, Hani Jneid, Gautam Kumar, Christopher J. White

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Purpose of Review: This article reviews the evidence on optimal medical therapy (OMT) versus coronary revascularization in patients with stable ischemic heart disease (SIHD) and advanced chronic kidney disease (CKD). Recent Findings: A post hoc analysis of the COURAGE trial in patients with SIHD and CKD showed no difference in freedom from angina, death, and nonfatal myocardial infarction (MI) between OMT and percutaneous intervention plus OMT compared with patients without CKD. The ISCHEMIA-CKD trial of 777 patients with advanced CKD revealed no difference in cumulative incidence of death or nonfatal MI at 3 years between OMT and revascularization but the composite of death or new dialysis was higher in the invasive arm. Additionally, there were no significant or sustained benefits in related to angina-related health status in invasive versus conservative strategy. Summary: An initial revascularization strategy does not reduce mortality or MI or relieve angina symptoms in patients with SIHD and advanced CKD.

Original languageEnglish (US)
Article number23
JournalCurrent Cardiology Reports
Volume23
Issue number4
DOIs
StatePublished - Apr 2021
Externally publishedYes

Keywords

  • Advanced chronic kidney disease
  • Coronary artery bypass graft
  • Optimal medical therapy
  • Percutaneous coronary intervention
  • Revascularization
  • Stable ischemic heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease'. Together they form a unique fingerprint.

Cite this